Occlusion of the central vein of the retina after recombinant hepatitis B vaccine;Occlusion de la veine centrale de la retine apres vaccination contre l'hepatite virale B par vaccin recombinant

Presse Medicale

Volumn 26, Issue 2, 1997, Pages 62-65

  Granel, B ^a   Disdier, P ^a   Devin, F ^b   Swiader, L ^a   Riss, J M ^a   Coupier, L ^a   Harle J R ^a   Jouglard, J ^c   Weiller, P J ^a  

^a TIMONE HOSPITAL   (France)

^b Service d'Ophtalmologie   (France)

^c Child and Adolescent Psychopathology Unit Salvator Hospital Public Assistance Marseille Hospitals University Aix Marseille II   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CORTICOSTEROID; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE; VASODILATOR AGENT;

ADULT; ARTICLE; CASE REPORT; EYE DISEASE; FEMALE; HEMODILUTION; HEPATITIS B; HUMAN; MALE; RETINA VEIN OCCLUSION;

ADULT; FEMALE; HEPATITIS B VACCINES; HUMANS; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; TIME FACTORS; VACCINES, SYNTHETIC;

EID: 0031053394     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Duclos P. Adverse events after hepatitis B vaccination. Can Med Assoc J 1992 ; 147:1023-6.
2. Devin F, Roques G, Disdier P, Rodor F, Weiller PJ. Occlusion of central retinal vein after hepatitis B vaccination. Lancet 1996 ; 347:1626.
3. Carmeli Y. Serious hepatitis B vaccine adverse reactions, are they immune-mediated? Vaccine 1993 ; 11:1358-9.
4. McMahon BJ, Helminiak C, Wainwright RB et al. Frequency of adverse reactions to hepatitis vaccine in 43,618 persons. Am J Med 1992 ; 92:254-6.
5. Mahassin F, Algayres JP, Valmary J et al. Myélite aiguë après vaccination contre l'hépatite B. Presse Med 1993 ; 22:1997-8.
6. Herroelen L, Keyser J, Ebinger G. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine. Lancet 1991 ; 338:1174-5.
7. Hudson TJ, Newkirk M, Gervais F, Shuster J. Adverse reaction to the recombinant hepatitis B vaccine. J Allergy Clin Immunol 1991 ; 88:821-2.
8. Brézin AP, Massin-Korobelnik P, Boundin M, Gaudric A, Phuc Le Hoang. Acute posterior multifocal placoid pigment epitheliopathy after hepatitis B vaccine. Arch Ophthalmol 1995 ; 113:297-300.
9. Fried M, Conen D, Conzelmann M, Steinemann E. Uvertis after hepatitis B vaccination. Lancet 1987 ; i:631-2.
10. Berkman N, Benzarti T, Dhaoui R, Mouly P. Neuropapillite bilatérale au décours de la vaccination contre l'hépatite virale B. Presse Med 1996 ; 25:1301.
11. Begaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inatendus ou toxiques des médicaments : actualisation de la méthode utilisée en France. Therapie 1985 ; 111-18.
12. Singh VK, Kalra HK, Yamaki K, Abe T, Donoso LA, Shinora T. Molecular mimicry between uveitopathogenic site of S-antigen and viral peptide. J Immunol 1990 ; 144:1282-7.
13. Fujinami RS, Oldstone MB. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985 ; 230:1043-5.
14. Brightman CAJ, Scadding GK, Dumbreck LA, Latchman Y, Brostoff J. Yeast-derived hepatitis B vaccine and yeast sensitivity. Lancet 1989 ; i:903.
15. Poullin P, Gabriel B. Thrombocytopenic purpura after recombinant hepatitis B vaccine. Lancet 1994 ; 344:1293.